The diverse applications of artificial intelligence are transforming industries at an unprecedented pace, but with great breakthroughs come complex challenges.Today I'm joined by Rajvir Madan, Chief Digital and Technology Officer at Arcutis Biotherapeutics, to break down the transformative impact AI is having in our field. Our discussion spans from the reduction of drug discovery timelines to addressing ethical concerns related to data biases. We also confront challenges tied to data quality and the implications for the workforce in the era of AI.To grasp the full spectrum of AI's influence on biotech and the vision it's charting for our future, tune in for a compelling episode.Specifically, this episode highlights the following themes:Dissecting AI impact on biotech AI benefits, cautious of challenges and ethicsAddressing challenges in digital transformation for businessesLinks from this episode:Get to know more about Steven Swan: https://www.linkedin.com/in/swangroupGet to know more about Rajvir Madan: https://www.linkedin.com/in/rajvir-raj-madan-3a74252

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related